Menu
11/08/2003
HRT users at greater risk of breast cancer, says research
Some kinds of hormone replacement therapy (HRT) have a much greater effect on a woman's risk of breast cancer than others, according to research published in the Lancet.
The Million Women Study, funded by Cancer Research UK, the NHS Breast Screening Programme and the Medical Research Council, has found that current and recent use of HRT increases a woman's chance of developing breast cancer and that the risk goes up with duration of use.
Current users of all types of HRT, including oestrogen-only, combined oestrogen-progestagen and tibolone, are at increased risk of breast cancer compared with women who have never used HRT. But the risk is substantially greater for users of combined preparations of HRT than for women on the other types, the research indicated.
Scientists at the Cancer Research UK Epidemiology Unit in Oxford analysed data from over one million women between the ages of 50 and 64.
Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non users (a 100% increase), while the risk increased by 45% among users of tibolone and by 30% among users of oestrogen-only HRT.
Professor Valerie Beral, Director of the Cancer Research UK Epidemiology Unit, said: "We estimate that over the past decade use of HRT by UK women aged 50-64 has resulted in an extra 20,000 breast cancers, oestrogen-progestagen therapy accounting for 15,000 of these.
"Since our results show a substantially greater increase in breast cancer with combined HRT, women need to weigh the increased risk of breast cancer caused by the addition of progestagen against the lowered risk of uterine cancer."
(gmcg)
The Million Women Study, funded by Cancer Research UK, the NHS Breast Screening Programme and the Medical Research Council, has found that current and recent use of HRT increases a woman's chance of developing breast cancer and that the risk goes up with duration of use.
Current users of all types of HRT, including oestrogen-only, combined oestrogen-progestagen and tibolone, are at increased risk of breast cancer compared with women who have never used HRT. But the risk is substantially greater for users of combined preparations of HRT than for women on the other types, the research indicated.
Scientists at the Cancer Research UK Epidemiology Unit in Oxford analysed data from over one million women between the ages of 50 and 64.
Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non users (a 100% increase), while the risk increased by 45% among users of tibolone and by 30% among users of oestrogen-only HRT.
Professor Valerie Beral, Director of the Cancer Research UK Epidemiology Unit, said: "We estimate that over the past decade use of HRT by UK women aged 50-64 has resulted in an extra 20,000 breast cancers, oestrogen-progestagen therapy accounting for 15,000 of these.
"Since our results show a substantially greater increase in breast cancer with combined HRT, women need to weigh the increased risk of breast cancer caused by the addition of progestagen against the lowered risk of uterine cancer."
(gmcg)
Related UK National News Stories
Click here for the latest headlines.
08 August 2003
HRT therapy can double breast cancer risk
Certain kinds of hormone replacement therapy (HRT) can double a woman's risk of breast cancer, according to major research study of more than a million women. Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non-users.
HRT therapy can double breast cancer risk
Certain kinds of hormone replacement therapy (HRT) can double a woman's risk of breast cancer, according to major research study of more than a million women. Researchers found that post-menopausal women using combination HRT were twice as likely to develop breast cancer as non-users.
05 August 2005
Breast cancer HRT risk lower than thought
A woman’s risk of developing breast cancer while taking hormone replacement therapy (HRT) might be lower than previously thought, according to new research.
Breast cancer HRT risk lower than thought
A woman’s risk of developing breast cancer while taking hormone replacement therapy (HRT) might be lower than previously thought, according to new research.
12 April 2006
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
Breast cancer patient wins Herceptin court battle
A breast cancer patient has won an appeal to receive the drug Herceptin on the NHS. Ann Marie Rogers, 54, from Swindon went to the Court of Appeal after the High Court ruled that Swindon Primary Care Trust had not acted unlawfully in refusing to give her the drug.
17 October 2005
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
Breast cancer can cost ‘thousands’
Breast cancer can cost sufferers thousands of pounds, a survey by a leading cancer charity has revealed. Macmillan Cancer Relief surveyed 50 cancer patients and found that, on average, they spent almost £2,000 on extra costs during their treatment.
27 June 2014
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
Blood Test Could Predict Breast Cancer - Research
A blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, according to research by the University College London (UCL).
-
Northern Ireland WeatherToday:Gale, coastal severe gale, northwest winds ease from late afternoon. Scattered showers will fall as snow over the hills at first, becoming isolated from mid-afternoon. Maximum temperature 7 °C.Tonight:Showers, scattered in the evening, will clear by midnight leaving the night dry with clear spells. Cloud will spread east towards morning. Minimum temperature 2 °C.
